Customized Dose Prescription for Permanent Prostate Brachytherapy: Insights From a Multicenter Analysis of Dosimetry Outcomes Academic Article uri icon

Overview

MeSH Major

  • Brachytherapy
  • Iodine Radioisotopes
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • These data suggest that permanent brachytherapy dose prescriptions can be customized to risk status. In low-risk patients, achieving a BED of >or=140 Gy might be adequate for prostate-specific antigen control. However, high-risk disease might require a BED dose of >or=200 Gy.

publication date

  • December 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ijrobp.2007.05.002

PubMed ID

  • 17689026

Additional Document Info

start page

  • 1472

end page

  • 7

volume

  • 69

number

  • 5